[Additional possibilities for correction of movement disorders induced by neuroleptics in patients with schizophrenia]

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(11):78-80.
[Article in Russian]
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Basal Ganglia Diseases / chemically induced*
  • Basal Ganglia Diseases / drug therapy*
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins
  • Male
  • Middle Aged
  • Movement Disorders / drug therapy*
  • Movement Disorders / etiology*
  • Peptides / therapeutic use*
  • Quality of Life
  • Schizophrenia, Paranoid / drug therapy*
  • Treatment Outcome
  • Young Adult

Substances

  • Antipsychotic Agents
  • Intercellular Signaling Peptides and Proteins
  • Peptides
  • cortexin